Type:Notice
Citation:90 FR 13881
Reading Time:about a minute or two
Promega Corporation has applied to the Drug Enforcement Administration to register as a bulk manufacturer of certain controlled substances. This notice invites comments or objections to the proposed registration by May 27, 2025. Comments must be submitted electronically through the Federal eRulemaking Portal at regulations.gov. The substances will be manufactured as Active Pharmaceutical Ingredients for sale to customers, with no other uses authorized.
Simple Explanation
Promega Corporation wants permission to make certain special medicines in large amounts, and people can say what they think about this by May 27, 2025, on a website called regulations.gov.